Literature DB >> 19279031

Functional and cognitive criteria produce different rates of mild cognitive impairment and conversion to dementia.

J Saxton1, B E Snitz, O L Lopez, D G Ives, L O Dunn, A Fitzpatrick, M C Carlson, S T Dekosky.   

Abstract

OBJECTIVE: To compare rates of mild cognitive impairment (MCI) and rates of progression to dementia using different MCI diagnostic systems.
METHODS: MCI was investigated at baseline in 3063 community dwelling non-demented elderly in the Ginkgo Evaluation of Memory (GEM) study who were evaluated every 6 months to identify the presence of dementia. Overall MCI frequency was determined using (1) a Clinical Dementia Rating (CDR) score of 0.5 and (2) neuropsychological (NP) criteria, defined by impairment on standard cognitive tests.
RESULTS: 40.2% of participants met CDR MCI criteria and 28.2% met NP MCI criteria (amnestic MCI = 16.6%). 15.7% were classified as MCI by both criteria and 47.4% as normal by both. Discordant diagnoses were observed in 24.5% who met NP normal/CDR MCI and in 12.4% who met NP MCI/CDR normal. Factors associated with CDR MCI among NP normal included lower education, lower NP scores, more instrumental activities of daily living impairment, greater symptoms of depression and subjective health problems. Individuals meeting NP MCI/CDR normal were significantly more likely to develop dementia over the median follow-up of 6.1 years than those meeting NP normal/CDR MCI.
CONCLUSIONS: Different criteria produce different MCI rates and different conversion rates to dementia. Although a higher percentage of MCI was identified by CDR than NP, a higher percentage of NP MCI progressed to dementia. These findings suggest that the CDR is sensitive to subtle changes in cognition not identified by the NP algorithm but is also sensitive to demographic and clinical factors probably leading to a greater number of false positives. These results suggest that identifying all individuals with CDR scores of 0.5 as Alzheimer's disease is not advisable.

Entities:  

Mesh:

Year:  2009        PMID: 19279031      PMCID: PMC2698042          DOI: 10.1136/jnnp.2008.160705

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  32 in total

1.  Normative data on the Boston Naming Test and two equivalent 30-item short forms.

Authors:  J Saxton; G Ratcliff; C A Munro; E C Coffey; J T Becker; L Fried; L Kuller
Journal:  Clin Neuropsychol       Date:  2000-11       Impact factor: 3.535

2.  Recruitment of the elderly into a pharmacologic prevention trial: the Ginkgo Evaluation of Memory Study experience.

Authors:  Annette L Fitzpatrick; Linda P Fried; Jeff Williamson; Patricia Crowley; Delilah Posey; Linly Kwong; Janet Bonk; Roberta Moyer; Joyce Chabot; Lara Kidoguchi; Curt D Furberg; Steven T DeKosky
Journal:  Contemp Clin Trials       Date:  2006-07-04       Impact factor: 2.226

3.  Mild cognitive impairment represents early-stage Alzheimer disease.

Authors:  J C Morris; M Storandt; J P Miller; D W McKeel; J L Price; E H Rubin; L Berg
Journal:  Arch Neurol       Date:  2001-03

4.  Predicting conversion to Alzheimer disease using standardized clinical information.

Authors:  E Daly; D Zaitchik; M Copeland; J Schmahmann; J Gunther; M Albert
Journal:  Arch Neurol       Date:  2000-05

5.  Distinction between preclinical Alzheimer's disease and depression.

Authors:  P J Visser; F R Verhey; R W Ponds; A Kester; J Jolles
Journal:  J Am Geriatr Soc       Date:  2000-05       Impact factor: 5.562

6.  Mild cognitive impairment, amnestic type: an epidemiologic study.

Authors:  Mary Ganguli; Hiroko H Dodge; Changyu Shen; Steven T DeKosky
Journal:  Neurology       Date:  2004-07-13       Impact factor: 9.910

7.  Prevalence and classification of mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 1.

Authors:  Oscar L Lopez; William J Jagust; Steven T DeKosky; James T Becker; Annette Fitzpatrick; Corinne Dulberg; John Breitner; Constantine Lyketsos; Beverly Jones; Claudia Kawas; Michelle Carlson; Lewis H Kuller
Journal:  Arch Neurol       Date:  2003-10

8.  Subclassifications for mild cognitive impairment: prevalence and predictive validity.

Authors:  A Busse; J Bischkopf; S G Riedel-Heller; M C Angermeyer
Journal:  Psychol Med       Date:  2003-08       Impact factor: 7.723

9.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

10.  Evaluation of dementia in the cardiovascular health cognition study.

Authors:  Oscar L Lopez; Lewis H Kuller; Annette Fitzpatrick; Diane Ives; James T Becker; Norman Beauchamp
Journal:  Neuroepidemiology       Date:  2003 Jan-Feb       Impact factor: 3.282

View more
  43 in total

Review 1.  Functional Disability in Mild Cognitive Impairment: A Systematic Review and Meta-Analysis.

Authors:  Cutter A Lindbergh; Rodney K Dishman; L Stephen Miller
Journal:  Neuropsychol Rev       Date:  2016-07-08       Impact factor: 7.444

2.  Subjective cognitive complaints contribute to misdiagnosis of mild cognitive impairment.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Douglas R Galasko; David P Salmon; Mark W Bondi
Journal:  J Int Neuropsychol Soc       Date:  2014-08-26       Impact factor: 2.892

3.  Susceptibility of the conventional criteria for mild cognitive impairment to false-positive diagnostic errors.

Authors:  Emily C Edmonds; Lisa Delano-Wood; Lindsay R Clark; Amy J Jak; Daniel A Nation; Carrie R McDonald; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon; Mark W Bondi
Journal:  Alzheimers Dement       Date:  2014-05-22       Impact factor: 21.566

4.  Outcomes of mild cognitive impairment by definition: a population study.

Authors:  Mary Ganguli; Beth E Snitz; Judith A Saxton; Chung-Chou H Chang; Ching-Wen Lee; Joni Vander Bilt; Tiffany F Hughes; David A Loewenstein; Frederick W Unverzagt; Ronald C Petersen
Journal:  Arch Neurol       Date:  2011-06

Review 5.  Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 1.

Authors:  Richard Mayeux; Christiane Reitz; Adam M Brickman; Mary N Haan; Jennifer J Manly; M Maria Glymour; Christopher C Weiss; Kristine Yaffe; Laura Middleton; Hugh C Hendrie; Lauren H Warren; Kathleen M Hayden; Kathleen A Welsh-Bohmer; John C S Breitner; John C Morris
Journal:  Alzheimers Dement       Date:  2011-01       Impact factor: 21.566

6.  Greater progression of coronary artery calcification is associated with clinically relevant cognitive impairment in type 1 diabetes.

Authors:  Jingchuan Guo; Karen A Nunley; Tina Costacou; Rachel G Miller; Caterina Rosano; Daniel Edmundowicz; Trevor J Orchard
Journal:  Atherosclerosis       Date:  2018-11-08       Impact factor: 5.162

7.  Neuropsychological criteria for mild cognitive impairment improves diagnostic precision, biomarker associations, and progression rates.

Authors:  Mark W Bondi; Emily C Edmonds; Amy J Jak; Lindsay R Clark; Lisa Delano-Wood; Carrie R McDonald; Daniel A Nation; David J Libon; Rhoda Au; Douglas Galasko; David P Salmon
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

8.  The association of age with rate of cognitive decline in elderly individuals residing in supporting care facilities.

Authors:  Ramit Ravona-Springer; Xiaodong Luo; James Schmeidler; Michael Wysocki; Gerson T Lesser; Michael A Rapp; Karen Dahlman; Hillel T Grossman; Vahram Haroutunian; Michal Schnaider Beeri
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Oct-Dec       Impact factor: 2.703

9.  How well do MCI criteria predict progression to severe cognitive impairment and dementia?

Authors:  Mary Ganguli; Ching-Wen Lee; Beth E Snitz; Tiffany F Hughes; Eric M McDade; Chung-Chou H Chang
Journal:  Alzheimer Dis Assoc Disord       Date:  2014 Apr-Jun       Impact factor: 2.703

10.  Mild Cognitive Impairment in Late Middle Age in the Wisconsin Registry for Alzheimer's Prevention Study: Prevalence and Characteristics Using Robust and Standard Neuropsychological Normative Data.

Authors:  Lindsay R Clark; Rebecca L Koscik; Christopher R Nicholas; Ozioma C Okonkwo; Corinne D Engelman; Lisa C Bratzke; Kirk J Hogan; Kimberly D Mueller; Barbara B Bendlin; Cynthia M Carlsson; Sanjay Asthana; Mark A Sager; Bruce P Hermann; Sterling C Johnson
Journal:  Arch Clin Neuropsychol       Date:  2016-11-22       Impact factor: 2.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.